{"database": "lobbying", "table": "lobbying_activities", "rows": [[627968, "d4ca2568-dc17-4143-9969-f34e039c9c70", "Q2", "STANTON PARK GROUP", 83717, "BARR LABORATORIES", 2008, "second_quarter", "PHA", "Generic Biologics HR 1956; S. 1695; HR 1038; S. 623; HR 5629; FDA Reform;", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2008-07-15T10:47:21-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["627968"], "units": {}, "query_ms": 35.74932098854333, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}